These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 8839663
1. Bioequivalence study of two enalapril maleate tablet formulations in healthy male volunteers. Pharmacokinetic versus pharmacodynamic approach. Ribeiro W, Muscará MN, Martins AR, Moreno H, Mendes GB, de Nucci G. Eur J Clin Pharmacol; 1996; 50(5):399-405. PubMed ID: 8839663 [Abstract] [Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic comparative study of zofenopril and enalapril in healthy volunteers. Marzo A, Dal Bo L, Mazzucchelli P, Monti NC, Crivelli F, Ismaili S, Giusti A, Uhr MR. Arzneimittelforschung; 2002; 52(4):233-42. PubMed ID: 12040965 [Abstract] [Full Text] [Related]
10. Determination of enalapril and enalaprilat by enzyme linked immunosorbent assays: application to pharmacokinetic and pharmacodynamic analysis. Matalka K, Arafat T, Hamad M, Jehanli A. Fundam Clin Pharmacol; 2002 Jun; 16(3):237-44. PubMed ID: 12165071 [Abstract] [Full Text] [Related]
11. Gender differences in angiotensin-converting enzyme (ACE) activity and inhibition by enalaprilat in healthy volunteers. Zapater P, Novalbos J, Gallego-Sandín S, Hernández FT, Abad-Santos F. J Cardiovasc Pharmacol; 2004 May; 43(5):737-44. PubMed ID: 15071363 [Abstract] [Full Text] [Related]
12. Bioequivalence study of two formulations of enalapril, at a single oral dose of 20 mg (tablets): A randomized, two-way, open-label, crossover study in healthy volunteers. Portolés A, Terleira A, Almeida S, García-Arenillas M, Caturla MC, Filipe A, Vargas E. Curr Ther Res Clin Exp; 2004 Jan; 65(1):34-46. PubMed ID: 24936102 [Abstract] [Full Text] [Related]
13. Enalapril pharmacokinetics and ACE inhibition, following single and chronic oral dosing. Edeki T, Johnston A, Li Kam Wa E, Turner P. Int J Clin Pharmacol Ther; 1994 Mar; 32(3):142-6. PubMed ID: 8205376 [Abstract] [Full Text] [Related]
16. Pharmacokinetics and converting enzyme inhibition after morning and evening administration of oral enalapril to healthy subjects. Weisser K, Schloos J, Lehmann K, Düsing R, Vetter H, Mutschler E. Eur J Clin Pharmacol; 1991 Mar; 40(1):95-9. PubMed ID: 1647954 [Abstract] [Full Text] [Related]
17. Pharmacokinetic assessment of an oral enalapril suspension for use in children. Rippley RK, Connor J, Boyle J, Bradstreet TE, Hand E, Lo MW, Murphy MG. Biopharm Drug Dispos; 2000 Dec; 21(9):339-44. PubMed ID: 11523062 [Abstract] [Full Text] [Related]
18. Kinetics and dynamics of enalapril in patients with liver cirrhosis. Ohnishi A, Tsuboi Y, Ishizaki T, Kubota K, Ohno T, Yoshida H, Kanezaki A, Tanaka T. Clin Pharmacol Ther; 1989 Jun; 45(6):657-65. PubMed ID: 2543535 [Abstract] [Full Text] [Related]
19. Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol. Bendtsen F, Henriksen JH. J Hum Hypertens; 1989 Jun; 3 Suppl 1():139-45. PubMed ID: 2550636 [Abstract] [Full Text] [Related]
20. Relative Bioavailability of Enalapril Administered as Orodispersible Minitablets in Healthy Adults. Van Hecken A, Burckhardt BB, Khalil F, de Hoon J, Klingmann I, Herbots M, Laeer S, Lagler FB, Breitkreutz J. Clin Pharmacol Drug Dev; 2020 Feb; 9(2):203-213. PubMed ID: 31411383 [Abstract] [Full Text] [Related] Page: [Next] [New Search]